Claim there was ‘never a deal to be done’ with Bristol Myers Squibb came after the original report led to a 9% slide in the FTSE 100 company’s shares
James Hurley is the Assistant Business Editor at The Times. He focuses on corporate misconduct, private companies, and entrepreneurship while also overseeing the business section's weekend coverage and significant events like the budget and the Times CEO Summit. James has been featured in various publications, including The University of Melbourne, The Guardian, and The Australian.












